In 2024, a comprehensive systematic review found evidence to suggest the benefits of fasting, including IF, in reducing the population risk of cardiovascular disease
But the direction changed today
Understanding what happens during this quarter-year timeline helps set realistic expectations and maintain commitment to treatment
Depending on provider evaluation, eligible patients may discuss GLOW Blend, Wolverine Blend, GHK-Cu, Sermorelin, Tesamorelin, Ipamorelin, CJC-1295, and KLOW as part of a personalized wellness plan
References: Hira T, Trakooncharoenvit A, Taguchi H, Hara H
Glucagon-Like Peptide 1 A hyperglycaemic factor was discovered in the pancreatic islets within two years of the identification of insulin in 1921